David A. Socks, Director at Phathom Pharmaceuticals, Inc. (PHAT), sold 154,016 shares at $47.35 ($6.7M) on 2020-12-16, disclosed to the SEC on 2020-12-18.
Open-market sale of $6.7M PHAT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.22 | 5,000 | $231K | 3.5% |
| 2 | $47.35 | 13,292 | $629K | 9.4% |
| 3 | $47.35 | 13,292 | $629K | 9.4% |
| 4 | $48.19 | 12,954 | $624K | 9.4% |
| 5 | $48.19 | 12,954 | $624K | 9.4% |
| 6 | $48.99 | 200 |
| $10K |
| 0.1% |
| 7 | $40.49 | 35,197 | $1.4M | 21.4% |
| 8 | $40.49 | 35,197 | $1.4M | 21.4% |
| 9 | $41.43 | 12,915 | $535K | 8.0% |
| 10 | $41.43 | 12,915 | $535K | 8.0% |
| 11 | $42.00 | 100 | $4K | 0.1% |
| Total | $43.33 avg | 154,016 | $6.7M | 100% |
| Filing → |
| PHAT | SELL | 2021-08-18 | $1.1M | — | Filing → |
| PHAT | SELL | 2021-06-29 | $2.2M | — | Filing → |
| PHAT | SELL | 2021-05-21 | $2.6M | — | Filing → |